title: Anti-angiogenic effect of high doses of ascorbic acid.
abstract: Pharmaceutical doses of ascorbic acid (AA, vitamin C, or its salts) have been reported to exert anticancer activity in vitro and in vivo. One proposed mechanism involves direct cytotoxicity mediated by accumulation of ascorbic acid radicals and hydrogen peroxide in the extracellular environment of tumor cells. However, therapeutic effects have been reported at concentrations insufficient to induce direct tumor cell death. We hypothesized that AA may exert anti-angiogenic effects. To test this, we expanded endothelial progenitor cells (EPCs) from peripheral blood and assessed, whether or not high dose AA would inhibit EPC ability to migrate, change energy metabolism, and tube formation ability. We also evaluated the effects of high dose AA on angiogenic activities of HUVECs (human umbilical vein endothelial cells) and HUAECs (human umbilical arterial endothelial cells). According to our data, concentrations of AA higher than 100 mg/dl suppressed capillary-like tube formation on Matrigel for all cells tested and the effect was more pronounced for progenitor cells in comparison with mature cells. Co-culture of differentiated endothelial cells with progenitor cells showed that there was incorporation of EPCs in vessels formed by HUVECs and HUAECs. Cell migration was assessed using an in vitro wound healing model. The results of these experiments showed an inverse correlation between AA concentrations relative to both cell migration and gap filling capacity. Suppression of NO (nitric oxide) generation appeared to be one of the mechanisms by which AA mediated angiostatic effects. This study supports further investigation into non-cytotoxic antitumor activities of AA.
authors.affiliation: Bio-Communications Research Institute, Wichita, Kansas, USA. nmikirova@brightspot.org
authors.forename: Nina A
authors.initials: NA
authors.lastname: Mikirova
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Ichim
authors.forename: Neil H
authors.initials: NH
authors.lastname: Riordan
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology; D001205:Ascorbic Acid / Q000494:pharmacology*; D002465:Cell Movement / Q000187:drug effects; D002469:Cell Separation; D002478:Cells, Cultured; D003094:Collagen / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D042783:Endothelial Cells / Q000166:cytology / Q000187:drug effects; D006801:Humans; D007797:Laminin / Q000378:metabolism; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D018919:Neovascularization, Physiologic / Q000187:drug effects; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D011509:Proteoglycans / Q000378:metabolism; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects; D014470:Umbilical Cord / Q000166:cytology
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D004338:Drug Combinations; D007797:Laminin; D011509:Proteoglycans; C059485:matrigel; D009569:Nitric Oxide; D003094:Collagen; D001205:Ascorbic Acid; D019331:NG-Nitroarginine Methyl Ester
references.citation: Arch Ophthalmol. 1990 Sep;108(9):1323-5
references.pmid: 2095758
references.citation: Integr Cancer Ther. 2005 Mar;4(1):32-44
references.pmid: 15695476
references.citation: J Nutr Sci Vitaminol (Tokyo). 1994 Jun;40(3):219-27
references.pmid: 7965211
references.citation: Blood. 2000 Feb 1;95(3):952-8
references.pmid: 10648408
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13604-9
references.pmid: 16157892
references.citation: J Cell Physiol. 1977 Jan;90(1):61-70
references.pmid: 833212
references.citation: Nat Med. 2001 Nov;7(11):1194-201
references.pmid: 11689883
references.citation: Circ Res. 1999 Aug 6;85(3):221-8
references.pmid: 10436164
references.citation: CMAJ. 2006 Mar 28;174(7):937-42
references.pmid: 16567755
references.citation: Cancer Res. 2003 Sep 15;63(18):5866-73
references.pmid: 14522911
references.citation: P R Health Sci J. 2004 Jun;23(2):115-8
references.pmid: 15377059
references.citation: Neoplasia. 2007 Jan;9(1):47-56
references.pmid: 17325743
references.citation: World J Gastroenterol. 2003 Nov;9(11):2565-9
references.pmid: 14606098
references.citation: Blood. 2004 Apr 1;103(7):2577-84
references.pmid: 14630797
references.citation: Am J Pathol. 1999 Oct;155(4):1381-90
references.pmid: 10514420
references.citation: P R Health Sci J. 2008 Mar;27(1):7-19
references.pmid: 18450228
references.citation: J Natl Cancer Inst. 1998 Apr 15;90(8):587-96
references.pmid: 9554441
references.citation: Cell. 2005 May 6;121(3):335-48
references.pmid: 15882617
references.citation: Arterioscler Thromb Vasc Biol. 2000 Mar;20(3):659-66
references.pmid: 10712388
references.citation: Trends Mol Med. 2004 Apr;10(4):143-5
references.pmid: 15162796
references.citation: Cancer Res. 2004 Dec 1;64(23):8492-5
references.pmid: 15574751
references.citation: Circ Res. 2003 Nov 28;93(11):1023-5
references.pmid: 14605020
references.citation: Nat Med. 2004 Sep;10(9):950-8
references.pmid: 15334073
references.citation: Am J Physiol Endocrinol Metab. 2006 Jun;290(6):E1131-9
references.pmid: 16352673
references.citation: J Clin Invest. 2000 Jan;105(1):71-7
references.pmid: 10619863
references.citation: J Korean Med Sci. 2007 Feb;22(1):7-11
references.pmid: 17297243
references.citation: Circ Res. 2001 Feb 2;88(2):167-74
references.pmid: 11157668
references.citation: Blood. 2004 Oct 1;104(7):2084-6
references.pmid: 15191949
references.citation: Cancer Cell. 2004 Oct;6(4):409-21
references.pmid: 15488763
references.citation: Nat Med. 2002 Jun;8(6):607-12
references.pmid: 12042812
references.citation: BMC Cell Biol. 2006 Apr 04;7:17
references.pmid: 16584574
references.citation: Graefes Arch Clin Exp Ophthalmol. 2007 Oct;245(10):1461-7
references.pmid: 17318569
references.citation: Am J Physiol. 1999 Oct;277(4):H1600-8
references.pmid: 10516200
references.citation: Proc Natl Acad Sci U S A. 1995 May 9;92(10):4392-6
references.pmid: 7538668
references.citation: Nat Med. 2003 Jun;9(6):789-95
references.pmid: 12740570
references.citation: Cancer Cell. 2003 Jul;4(1):31-9
references.pmid: 12892711
references.citation: Antioxid Redox Signal. 2001 Feb;3(1):157-63
references.pmid: 11291594
references.citation: Cancer Res. 2005 Nov 1;65(21):9741-50
references.pmid: 16266995
references.citation: Br J Cancer. 2001 Jun 1;84(11):1544-50
references.pmid: 11384106
references.citation: J Pharmacol Exp Ther. 1996 Jun;277(3):1719-25
references.pmid: 8667243